Radiation necrosis or tumor progression? A review of the radiographic modalities used in the diagnosis of cerebral radiation necrosis

[1]  G. Barnett,et al.  Time to Steroid Independence After Laser Interstitial Thermal Therapy vs Medical Management for Treatment of Biopsy-Proven Radiation Necrosis Secondary to Stereotactic Radiosurgery for Brain Metastasis , 2022, Neurosurgery.

[2]  C. Greco,et al.  The role of feature-based radiomics for predicting response and radiation injury after stereotactic radiation therapy for brain metastases: A critical review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (yAIRO) , 2021, Translational oncology.

[3]  N. Obuchowski,et al.  18F-Fluciclovine PET/CT to Distinguish Radiation Necrosis From Tumor Progression in Brain Metastases Treated With Stereotactic Radiosurgery: Results of a Prospective Pilot Study. , 2021, International journal of radiation oncology, biology, physics.

[4]  Stefano Casagranda,et al.  Current emerging MRI tools for radionecrosis and pseudoprogression diagnosis , 2021, Current opinion in oncology.

[5]  K. Abdullah,et al.  Bevacizumab vs laser interstitial thermal therapy in cerebral radiation necrosis from brain metastases: a systematic review and meta-analysis , 2021, Journal of Neuro-Oncology.

[6]  Douglas C. Miller,et al.  Reliability of MR Spectroscopy and PET CT in Differentiating Metastatic Brain Tumor Recurrence from Radiation Necrosis. , 2021, World neurosurgery.

[7]  K. Merrell,et al.  Intracranial long-term complications of radiation therapy: an image-based review , 2021, Neuroradiology.

[8]  Raymond Y Huang,et al.  Immune checkpoint inhibitor therapy may increase the incidence of treatment-related necrosis after stereotactic radiosurgery for brain metastases: a systematic review and meta-analysis , 2020, European Radiology.

[9]  M. Mamede,et al.  Long-term metabolic evolution of brain metastases with suspected radiation necrosis following stereotactic radiosurgery: longitudinal assessment by F-DOPA PET. , 2020, Neuro-oncology.

[10]  Ephraim E. Parent,et al.  [18F]-Fluciclovine PET discrimination of recurrent intracranial metastatic disease from radiation necrosis , 2020, EJNMMI Research.

[11]  P. Brown,et al.  A nomogram to predict symptomatic epilepsy in patients with radiation-induced brain necrosis , 2020, Neurology.

[12]  J. Salleron,et al.  Radiomics Method for the Differential Diagnosis of Radionecrosis Versus Progression after Fractionated Stereotactic Body Radiotherapy for Brain Oligometastasis , 2020, Radiation Research.

[13]  Kenta Miwa,et al.  11C-methionine-PET for differentiating recurrent brain tumor from radiation necrosis: radiomics approach with random forest classifier , 2019, Scientific Reports.

[14]  Ian Law,et al.  PET imaging in patients with brain metastasis-report of the RANO/PET group. , 2019, Neuro-oncology.

[15]  Kei Yamada,et al.  Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review , 2019, Radiation oncology.

[16]  Jennifer S. Yu,et al.  Overall survival and response to radiation and targeted therapies among patients with renal cell carcinoma brain metastases. , 2019, Journal of neurosurgery.

[17]  Pierre-Yves Bondiau,et al.  18F-DOPA PET/CT in brain tumors: impact on multidisciplinary brain tumor board decisions , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  A. Redig,et al.  Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic Radiation , 2018, JAMA oncology.

[19]  Y. Tao,et al.  Diagnostic Accuracy of Amino Acid and FDG-PET in Differentiating Brain Metastasis Recurrence from Radionecrosis after Radiotherapy: A Systematic Review and Meta-Analysis , 2017, American Journal of Neuroradiology.

[20]  Jing Li,et al.  A predictive model for distinguishing radiation necrosis from tumour progression after gamma knife radiosurgery based on radiomic features from MR images , 2018, European Radiology.

[21]  S. Yomo,et al.  Prospective study of 11C–methionine PET for distinguishing between recurrent brain metastases and radiation necrosis: limitations of diagnostic accuracy and long-term results of salvage treatment , 2017, BMC Cancer.

[22]  H. Lanfermann,et al.  Radiation injury versus malignancy after stereotactic radiosurgery for brain metastases: impact of time-dependent changes in lesion morphology on MRI , 2016, Neuro-oncology.

[23]  Gereon R. Fink,et al.  Dynamic O-(2-18F-fluoroethyl)-L-tyrosine positron emission tomography differentiates brain metastasis recurrence from radiation injury after radiotherapy , 2016, Neuro-oncology.

[24]  N. Albert,et al.  Suspected recurrence of brain metastases after focused high dose radiotherapy: can [18F]FET- PET overcome diagnostic uncertainties? , 2016, Radiation oncology.

[25]  K. Peck,et al.  A prospective trial of dynamic contrast-enhanced MRI perfusion and fluorine-18 FDG PET-CT in differentiating brain tumor progression from radiation injury after cranial irradiation. , 2016, Neuro-oncology.

[26]  E. Kasper,et al.  Diagnostic Accuracy of PET, SPECT, and Arterial Spin-Labeling in Differentiating Tumor Recurrence from Necrosis in Cerebral Metastasis after Stereotactic Radiosurgery , 2015, American Journal of Neuroradiology.

[27]  A. Akabane,et al.  Differentiation of Brain Tumor Recurrence from Post-Radiotherapy Necrosis with 11C-Methionine PET: Visual Assessment versus Quantitative Assessment , 2015, PloS one.

[28]  M. McDermott,et al.  Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors. , 2015, Journal of neurosurgery.

[29]  Fang-Fang Yin,et al.  Defining the optimal planning target volume in image-guided stereotactic radiosurgery of brain metastases: results of a randomized trial. , 2015, International journal of radiation oncology, biology, physics.

[30]  H.S. Kim,et al.  Utility of Intravoxel Incoherent Motion MR Imaging for Distinguishing Recurrent Metastatic Tumor from Treatment Effect following Gamma Knife Radiosurgery: Initial Experience , 2014, American Journal of Neuroradiology.

[31]  Francesco Scopinaro,et al.  Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[32]  Samuel T Chao,et al.  Challenges with the diagnosis and treatment of cerebral radiation necrosis. , 2013, International journal of radiation oncology, biology, physics.

[33]  T. Nihashi,et al.  Diagnostic Accuracy of PET for Recurrent Glioma Diagnosis: A Meta-Analysis , 2013, American Journal of Neuroradiology.

[34]  H. Herzog,et al.  Role of O-(2-18F-Fluoroethyl)-l-Tyrosine PET for Differentiation of Local Recurrent Brain Metastasis from Radiation Necrosis , 2012, The Journal of Nuclear Medicine.

[35]  Surjith Vattoth,et al.  Radiation necrosis in the brain: imaging features and differentiation from tumor recurrence. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.

[36]  G. Barnett,et al.  Conventional MRI does not reliably distinguish radiation necrosis from tumor recurrence after stereotactic radiosurgery , 2012, Journal of Neuro-Oncology.

[37]  D. Born,et al.  Radiation Necrosis: Relevance with Respect to Treatment of Primary and Secondary Brain Tumors , 2012, Current Neurology and Neuroscience Reports.

[38]  S. Kim,et al.  Analysis of the layering pattern of the apparent diffusion coefficient (ADC) for differentiation of radiation necrosis from tumour progression , 2012, European Radiology.

[39]  A. Bozzao,et al.  Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis , 2011, Radiation oncology.

[40]  Edward M. Hsiao,et al.  Dual phase FDG-PET imaging of brain metastases provides superior assessment of recurrence versus post-treatment necrosis , 2011, Journal of Neuro-Oncology.

[41]  D. Kondziolka,et al.  T1/T2 Matching to Differentiate Tumor Growth From Radiation Effects After Stereotactic Radiosurgery , 2010, Neurosurgery.

[42]  M. Endo,et al.  Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery , 2010, Journal of Neuro-Oncology.

[43]  J E Heiserman,et al.  Relative Cerebral Blood Volume Values to Differentiate High-Grade Glioma Recurrence from Posttreatment Radiation Effect: Direct Correlation between Image-Guided Tissue Histopathology and Localized Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging Measurements , 2009, American Journal of Neuroradiology.

[44]  M R Segal,et al.  Distinguishing Recurrent Intra-Axial Metastatic Tumor from Radiation Necrosis Following Gamma Knife Radiosurgery Using Dynamic Susceptibility-Weighted Contrast-Enhanced Perfusion MR Imaging , 2008, American Journal of Neuroradiology.

[45]  W. Friedman,et al.  CAN STANDARD MAGNETIC RESONANCE IMAGING RELIABLY DISTINGUISH RECURRENT TUMOR FROM RADIATION NECROSIS AFTER RADIOSURGERY FOR BRAIN METASTASES? A RADIOGRAPHIC‐PATHOLOGICAL STUDY , 2008, Neurosurgery.

[46]  Shigeaki Higashiyama,et al.  Diagnostic Accuracy of 11C-Methionine PET for Differentiation of Recurrent Brain Tumors from Radiation Necrosis After Radiotherapy , 2008, Journal of Nuclear Medicine.

[47]  J. Ruben,et al.  Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy. , 2006, International journal of radiation oncology, biology, physics.

[48]  Wei Chen,et al.  18F-FDOPA PET imaging of brain tumors: comparison study with 18F-FDG PET and evaluation of diagnostic accuracy. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[49]  K. Takakura,et al.  Differentiation of the Radiation-Induced Necrosis and Tumor Recurrence after Gamma Knife Radiosurgery for Brain Metastases: Importance of Multi-Voxel Proton MRS , 2005, Minimally invasive neurosurgery : MIN.

[50]  A. Yamaura,et al.  Diagnostic value of thallium-201 chloride single-photon emission computerized tomography in differentiating tumor recurrence from radiation injury after gamma knife surgery for metastatic brain tumors. , 2005, Journal of neurosurgery.

[51]  K. Ohata,et al.  Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? , 2003, Journal of neurosurgery.

[52]  G. Barnett,et al.  The sensitivity and specificity of FDG PET in distinguishing recurrent brain tumor from radionecrosis in patients treated with stereotactic radiosurgery , 2001, International journal of cancer.

[53]  D. Kondziolka,et al.  Distinguishing Recurrent Tumor and Radiation Necrosis with Positron Emission Tomography versus Stereotactic Biopsy , 2000, Stereotactic and Functional Neurosurgery.

[54]  B. Drayer,et al.  Differentiating recurrent tumor from radiation necrosis: time for re-evaluation of positron emission tomography? , 1998, AJNR. American journal of neuroradiology.

[55]  K. Houkin,et al.  Differentiation of cerebral radiation necrosis from tumor recurrence by proton magnetic resonance spectroscopy. , 1997, Neurologia medico-chirurgica.

[56]  E. Shaw,et al.  Radiosurgery for the treatment of previously irradiated recurrent primary brain tumors and brain metastases: initial report of radiation therapy oncology group protocol (90-05). , 1996, International journal of radiation oncology, biology, physics.

[57]  D. Podoloff,et al.  Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET. , 1992, Radiographics : a review publication of the Radiological Society of North America, Inc.

[58]  J. Marks,et al.  Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume. , 1981, International journal of radiation oncology, biology, physics.